Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mahyco is one of India's largest private sector seed companies specializing in research-driven development of high-yielding hybrid seeds as well as genetically engineered crops. It pioneered the introduction of transgenic Bollgard® cotton (Bt cotton) to India through its joint venture with Monsanto. The company's portfolio includes over a hundred products across more than thirty crop species—cereals, oilseeds, fiber crops like cotton, vegetables—and it has developed insect-resistant varieties such as Bt brinjal and Bt okra that have completed regulatory trials but await commercialization approval. Its R&D focuses on molecular breeding/genomics/crop transformation for improved yield, stress tolerance, pest resistance and input efficiency traits.[2][6][7][9]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mahyco.